Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Completed · Phase 2
Conditions studied: Lung Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining topotecan, carboplatin, and etoposide in treating patients who have extensive-stage small cell lung cancer.
Key facts
- Study ID
- NCT00025272
- Run by
- Wake Forest University Health Sciences
- People needed
- 14
- Starts
- 2001-11-01
- Expected to finish
- 2005-01-18
- Last updated by the study team
- 2021-09-09
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Southeastern Medical Oncology Center — Goldsboro, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
- CCOP - Greenville — Greenville, South Carolina, United States
- CCOP - Upstate Carolina — Spartanburg, South Carolina, United States
- MBCCOP - Massey Cancer Center — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.